Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Cervical Cancer

  Free Subscription

Articles published in Gynecol Oncol

Retrieve available abstracts of 332 articles:
HTML format

Single Articles

    September 2021
  1. LUHRS O, Ekdahl L, Geppert B, Lonnerfors C, et al
    Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer.
    Gynecol Oncol. 2021 Sep 8. pii: S0090-8258(21)01328.
    PubMed     Abstract available

  2. QIN J, Shahangian S, Saraiya M, Holt H, et al
    Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
    Gynecol Oncol. 2021 Sep 7. pii: S0090-8258(21)01321.
    PubMed     Abstract available

  3. WU S, Ding X, Kong Y, Acharya S, et al
    The feature of cervical microbiota associated with the progression of cervical cancer among reproductive females.
    Gynecol Oncol. 2021 Sep 6. pii: S0090-8258(21)01314.
    PubMed     Abstract available

  4. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    From FIGO-2009 to FIGO-2018 in women with early-stage cervical cancer; Does the revised staging reflect risk groups?
    Gynecol Oncol. 2021 Sep 6. pii: S0090-8258(21)01324.
    PubMed     Abstract available

  5. VENKAT P, Salani R
    Changing paradigms in intermediate-risk cervical cancer: Sedlis revisited.
    Gynecol Oncol. 2021;162:527-528.

    August 2021
  6. MATZ M, Weir HK, Alkhalawi E, Coleman MP, et al
    Disparities in cervical cancer survival in the United States by race and stage at diagnosis: An analysis of 138,883 women diagnosed between 2001 and 2014 (CONCORD-3).
    Gynecol Oncol. 2021 Aug 25. pii: S0090-8258(21)01312.
    PubMed     Abstract available

  7. O'MALLEY DM, Oaknin A, Monk BJ, Selle F, et al
    Phase II study of the safety and efficacy of the anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer.
    Gynecol Oncol. 2021 Aug 24. pii: S0090-8258(21)01316.
    PubMed     Abstract available

    July 2021
  8. HRUDA M, Robova H, Rob L, Halaska MJ, et al
    Twenty years of experience with less radical fertility-sparing surgery in early-stage cervical cancer: Oncological outcomes.
    Gynecol Oncol. 2021 Jul 27. pii: S0090-8258(21)00593.
    PubMed     Abstract available

  9. TIWARI R, Narayanan GS, Reddy VP, Vishwanathan B, et al
    Impact of nodal boost irradiation and MR-based brachytherapy on oncologic outcomes in node-positive cervical cancer.
    Gynecol Oncol. 2021 Jul 22. pii: S0090-8258(21)00585.
    PubMed     Abstract available

  10. MURAKAMI N, Ando K, Murata M, Murata K, et al
    Why not de-intensification for uterine cervical cancer?
    Gynecol Oncol. 2021 Jul 19. pii: S0090-8258(21)00583.
    PubMed     Abstract available

  11. SPONHOLTZ SE, Mogensen O, Hildebrandt MG, Schledermann D, et al
    Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00512.
    PubMed     Abstract available

    June 2021
  12. LEVINSON K, Beavis AL, Purdy C, Rositch AF, et al
    Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: An NRG/GOG ancillary analysis.
    Gynecol Oncol. 2021 Jun 30. pii: S0090-8258(21)00511.
    PubMed     Abstract available

  13. ZHANG G, Zhang Y, He F, Wu H, et al
    Preoperative controlling nutritional status (CONUT) score is a prognostic factor for early-stage cervical cancer patients with high-risk factors.
    Gynecol Oncol. 2021 Jun 17. pii: S0090-8258(21)00492.
    PubMed     Abstract available

  14. BENITO V, Lubrano A, Perez-Regadera JF, Torne A, et al
    Postreatment squamous cell carcinoma antigen as a survival prognostic factor in patients with locally advanced cervical cancer. A Spanish multicenter study. The SEGO Spain-GOG group.
    Gynecol Oncol. 2021 Jun 9. pii: S0090-8258(21)00485.
    PubMed     Abstract available

  15. RONSINI C, Anchora LP, Restaino S, Fedele C, et al
    The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.
    Gynecol Oncol. 2021 Jun 9. pii: S0090-8258(21)00482.
    PubMed     Abstract available

  16. MILLS JM, Morgan JR, Dhaliwal A, Perkins RB, et al
    Eligibility for cervical cancer screening exit: Comparison of a national and safety net cohort.
    Gynecol Oncol. 2021 Jun 3. pii: S0090-8258(21)00441.
    PubMed     Abstract available

    May 2021
  17. SERT BM, Kristensen GB, Kleppe A, Dorum A, et al
    Long-term oncological outcomes and recurrence patterns in early-stage cervical cancer treated with minimally invasive versus abdominal radical hysterectomy: The Norwegian Radium Hospital experience.
    Gynecol Oncol. 2021 May 31. pii: S0090-8258(21)00434.
    PubMed     Abstract available

  18. BRODEUR MN, Dejean R, Beauchemin MC, Samouelian V, et al
    Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00429.
    PubMed     Abstract available

  19. SONG F, Belinson JL, Yan P, Huang X, et al
    Evaluation of p16(INK4a) immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00410.
    PubMed     Abstract available

  20. MATSUO K, Mandelbaum RS, Klar M, Ciesielski KM, et al
    Decreasing utilization of minimally invasive hysterectomy for cervical cancer in the United States.
    Gynecol Oncol. 2021 May 12. pii: S0090-8258(21)00364.
    PubMed     Abstract available

    April 2021
  21. DILLEY S, Huh W, Blechter B, Rositch AF, et al
    It's time to re-evaluate cervical Cancer screening after age 65.
    Gynecol Oncol. 2021 Apr 26. pii: S0090-8258(21)00347.
    PubMed     Abstract available

  22. FANG C, Zhang P, Yu A, Yang Y, et al
    Different prognosis of stage IIIB cervical cancer patients with lower third of vaginal invasion and those without.
    Gynecol Oncol. 2021 Apr 12. pii: S0090-8258(21)00275.
    PubMed     Abstract available

    March 2021
  23. MATSUO K, Huang Y, Matsuzaki S, Ragab OM, et al
    Association between definitive chemoradiotherapy wait-time and survival in locally-advanced cervical cancer: Implications during the coronavirus pandemic.
    Gynecol Oncol. 2021 Mar 23. pii: S0090-8258(21)00171.
    PubMed     Abstract available

  24. CHANG CL, Ho SC, Su YF, Juan YC, et al
    DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Gynecol Oncol. 2021 Mar 20. pii: S0090-8258(21)00148.
    PubMed     Abstract available

  25. ALHOLM Z, Monk BJ, Ting J, Pulgar S, et al
    Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis.
    Gynecol Oncol. 2021 Mar 16. pii: S0090-8258(21)00194.
    PubMed     Abstract available

  26. KIM J, Cho Y, Kim N, Chung SY, et al
    Magnetic resonance imaging-based validation of the 2018 FIGO staging system in patients treated with definitive radiotherapy for locally advanced cervix cancer.
    Gynecol Oncol. 2021;160:735-741.
    PubMed     Abstract available

    February 2021
  27. SKORSTENGAARD M, Frederiksen ME, Baillet MV, Beau AB, et al
    Cervical cancer survivors and health care use: A Danish population-based register study.
    Gynecol Oncol. 2021 Feb 19. pii: S0090-8258(21)00139.
    PubMed     Abstract available

  28. VARELA CAGETTI L, Gonzague-Casabianca L, Zemmour C, Lambaudie E, et al
    The impact of modern preoperative high-dose-rate brachytherapy in early-stage cervical cancer.
    Gynecol Oncol. 2021 Feb 6. pii: S0090-8258(21)00094.
    PubMed     Abstract available

  29. BROOKS SE, Davis EC, Farley JH
    Disparities in pap smear screening follow up: A catalyst for collective action vs. collective despair.
    Gynecol Oncol. 2021;160:361-363.

    January 2021
  30. KALJOUW S, Jansen EEL, Aitken CA, Harrijvan LM, et al
    Reducing unnecessary referrals for colposcopy in hrHPV-positive women within the Dutch cervical cancer screening programme: A modelling study.
    Gynecol Oncol. 2021 Jan 12. pii: S0090-8258(20)34253.
    PubMed     Abstract available

  31. ZAPARDIEL I, Kocian R, Kohler C, Klat J, et al
    Voiding recovery after radical parametrectomy in cervical cancer patients: An international prospective multicentre trial - SENTIX.
    Gynecol Oncol. 2021 Jan 5. pii: S0090-8258(20)34221.
    PubMed     Abstract available

  32. BOGANI G, Raspagliesi F, di Donato V, Brusadelli C, et al
    Spotlight on the role of human papillomavirus vaccines.
    Gynecol Oncol. 2021;160:346-350.
    PubMed     Abstract available

    December 2020
  33. DAHLMAN D, Li X, Magnusson H, Sundquist J, et al
    Cervical cancer among Swedish women with drug use disorders: A nationwide epidemiological study.
    Gynecol Oncol. 2020 Dec 31. pii: S0090-8258(20)34214.
    PubMed     Abstract available

  34. JOU J, Coulter E, Roberts T, Binder P, et al
    Assessment of malnutrition by unintentional weight loss and its implications on oncologic outcomes in patient with locally advanced cervical cancer receiving primary chemoradiation.
    Gynecol Oncol. 2020 Dec 17. pii: S0090-8258(20)34180.
    PubMed     Abstract available

  35. FACHINI AMD, Zuliani AC, Sarian LO, Teixeira JC, et al
    Long-term outcomes of concomitant cisplatin plus radiotherapy versus radiotherapy alone in patients with stage IIIB squamous cervical cancer: A randomized controlled trial.
    Gynecol Oncol. 2020 Dec 16. pii: S0090-8258(20)34157.
    PubMed     Abstract available

  36. FORD S, Tarraf W, Williams KP, Roman LA, et al
    Differences in cervical cancer screening and follow-up for black and white women in the United States.
    Gynecol Oncol. 2020 Dec 12. pii: S0090-8258(20)34155.
    PubMed     Abstract available

  37. PAREEK V, Barthwal M, Giridhar P, Patil PA, et al
    A phase III randomised trial of trans-abdominal ultrasound in improving application quality and dosimetry of intra-cavitary brachytherapy in locally advanced cervical cancer.
    Gynecol Oncol. 2020 Dec 6. pii: S0090-8258(20)34160.
    PubMed     Abstract available

  38. SPINILLO A, Dominoni M, Boschi AC, Cesari S, et al
    The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Gynecol Oncol. 2020;159:630-635.
    PubMed     Abstract available

  39. COHEN PA, Leung Y, Anderson L, van der Griend R, et al
    Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and
    Gynecol Oncol. 2020;159:623-629.
    PubMed     Abstract available

  40. BOGANI G, DI Donato V, Sopracordevole F, Ciavattini A, et al
    Recurrence rate after loop electrosurgical excision procedure (LEEP) and laser Conization: A 5-year follow-up study.
    Gynecol Oncol. 2020;159:636-641.
    PubMed     Abstract available

    November 2020
  41. STALEY SA, Tucker KR, Gehrig PA, Clark LH, et al
    Accuracy of preoperative cross-sectional imaging in cervical cancer patients undergoing primary radical surgery.
    Gynecol Oncol. 2020 Nov 16. pii: S0090-8258(20)34067.
    PubMed     Abstract available

  42. JANSEN EEL, Ivanus U, Jerman T, de Koning HJ, et al
    The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.
    Gynecol Oncol. 2020 Nov 13. pii: S0090-8258(20)34058.
    PubMed     Abstract available

  43. DE LA MOTTE ROUGE T, Touboul C, Lhomel C, Roupret M, et al
    Factors associated with compliance to cervical cancer screening in France: The EDIFICE 6 survey.
    Gynecol Oncol. 2020 Nov 3. pii: S0090-8258(20)34054.
    PubMed     Abstract available

    Insurance and adherence to guideline concordant cervical cancer therapy do not reduce mortality?
    Gynecol Oncol. 2020;159:297-298.

    October 2020
  45. HAN X, Liu S, Yang G, Hosseinifard H, et al
    Prognostic value of systemic hemato-immunological indices in uterine cervical cancer: A systemic review, meta-analysis, and meta-regression of observational studies.
    Gynecol Oncol. 2020 Oct 19. pii: S0090-8258(20)34019.
    PubMed     Abstract available

  46. HUNG P, Zahnd WE, Brandt HM, Adams SA, et al
    Cervical cancer treatment initiation and survival: The role of residential proximity to cancer care.
    Gynecol Oncol. 2020 Oct 17. pii: S0090-8258(20)34014.
    PubMed     Abstract available

  47. KWON BS, Roh HJ, Lee S, Yang J, et al
    Comparison of long-term survival of total abdominal radical hysterectomy and laparoscopy-assisted radical vaginal hysterectomy in patients with early cervical cancer: Korean multicenter, retrospective analysis.
    Gynecol Oncol. 2020 Oct 8. pii: S0090-8258(20)33945.
    PubMed     Abstract available

  48. BAO H, Bi H, Zhang X, Zhao Y, et al
    Artificial intelligence-assisted cytology for detection of cervical intraepithelial neoplasia or invasive cancer: A multicenter, clinical-based, observational study.
    Gynecol Oncol. 2020;159:171-178.
    PubMed     Abstract available

    September 2020
  49. CHINO J, Annunziata CM, Beriwal S, Bradfield L, et al
    The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
    Gynecol Oncol. 2020 Sep 22. pii: S0090-8258(20)33908.

  50. LANDY R, Mathews C, Robertson M, Wiggins CL, et al
    A state-wide population-based evaluation of cervical cancers arising during opportunistic screening in the United States.
    Gynecol Oncol. 2020 Sep 22. pii: S0090-8258(20)33850.
    PubMed     Abstract available

  51. YOSHIMOTO Y, Sasaki Y, Murata K, Noda SE, et al
    Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
    Gynecol Oncol. 2020 Sep 17. pii: S0090-8258(20)33821.
    PubMed     Abstract available

  52. LI C, Li X, You J, Liang B, et al
    Impact of radiation source activity on short- and long-term outcomes of cervical carcinoma patients treated with high-dose-rate brachytherapy: A retrospective cohort study.
    Gynecol Oncol. 2020 Sep 12. pii: S0090-8258(20)33854.
    PubMed     Abstract available

  53. ADAM JA, van Diepen PR, Mom CH, Stoker J, et al
    [(18)F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature.
    Gynecol Oncol. 2020 Sep 10. pii: S0090-8258(20)33822.
    PubMed     Abstract available

  54. RISCHIN D, Gil-Martin M, Gonzalez-Martin A, Brana I, et al
    PD-1 blockade in recurrent or metastatic cervical cancer: Data from cemiplimab phase I expansion cohorts and characterization of PD-L1 expression in cervical cancer.
    Gynecol Oncol. 2020 Sep 8. pii: S0090-8258(20)33827.
    PubMed     Abstract available

  55. YANG J, Mead-Harvey C, Polen-De C, Magtibay P, et al
    Survival outcomes in patients with cervical cancer treated with open versus robotic radical hysterectomy: Our surgical pathology interrogation.
    Gynecol Oncol. 2020 Sep 3. pii: S0090-8258(20)33832.
    PubMed     Abstract available

  56. VETTER MH, Smrz S, Gehrig PA, Peng K, et al
    Pathologic and clinical tumor size discordance in early-stage cervical cancer: Does it matter?
    Gynecol Oncol. 2020 Sep 2. pii: S0090-8258(20)33760.
    PubMed     Abstract available

  57. CAO D, Shen K, Chen Y, Xu Y, et al
    Value of endocervical curettage in follow-up for patients with cervical intraepithelial neoplasia stage 2+ after loop electrosurgical excision.
    Gynecol Oncol. 2020;158:584-589.
    PubMed     Abstract available

  58. FRUMOVITZ M, Westin SN, Salvo G, Zarifa A, et al
    Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract.
    Gynecol Oncol. 2020;158:570-575.
    PubMed     Abstract available

    August 2020
  59. DE JAEGHERE EA, Laloo F, Lippens L, Van Bockstal M, et al
    Splenic (18)F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer.
    Gynecol Oncol. 2020 Aug 25. pii: S0090-8258(20)33757.
    PubMed     Abstract available

  60. OHNO A, Iwata T, Katoh Y, Taniguchi S, et al
    Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Gynecol Oncol. 2020 Aug 20. pii: S0090-8258(20)33756.
    PubMed     Abstract available

  61. GURRAM L, Patil R, Chopra S, Maheshwari A, et al
    Evaluation of outcomes in patients of cervical Cancer with lower one third vaginal involvement: A single institutional experience.
    Gynecol Oncol. 2020 Aug 20. pii: S0090-8258(20)33809.
    PubMed     Abstract available

  62. MAULARD A, Chargari C, Faron M, Alwohaibi A, et al
    A new score based on biomarker values to predict the prognosis of locally advanced cervical cancer.
    Gynecol Oncol. 2020 Aug 19. pii: S0090-8258(20)33758.
    PubMed     Abstract available

  63. WU J, Huang Y, Tergas AI, Melamed A, et al
    The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer.
    Gynecol Oncol. 2020 Aug 14. pii: S0090-8258(20)33762.
    PubMed     Abstract available

  64. KNOTH J, Potter R, Jurgenliemk-Schulz IM, Haie-Meder C, et al
    Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study.
    Gynecol Oncol. 2020 Aug 11. pii: S0090-8258(20)32382.
    PubMed     Abstract available

  65. REDONDO A, Colombo N, McCormack M, Dreosti L, et al
    Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
    Gynecol Oncol. 2020 Aug 4. pii: S0090-8258(20)33661.
    PubMed     Abstract available

  66. NICA A, Covens A
    Cone biopsy (with pelvic lymphadenectomy) for fertility preservation in early stage cervical cancer: Ready for prime time?
    Gynecol Oncol. 2020;158:229-230.

    July 2020
  67. PARK JY, Chong GO, Park JY, Chung D, et al
    Tumor budding in cervical cancer as a prognostic factor and its possible role as an additional intermediate-risk factor.
    Gynecol Oncol. 2020 Jul 30. pii: S0090-8258(20)33665.
    PubMed     Abstract available

  68. SIMMS KT, Yuill S, Killen J, Smith MA, et al
    Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions.
    Gynecol Oncol. 2020 Jul 25. pii: S0090-8258(20)31099.
    PubMed     Abstract available

  69. OAKNIN A, Friedman CF, Roman LD, D'Souza A, et al
    Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trial.
    Gynecol Oncol. 2020 Jul 25. pii: S0090-8258(20)33660.
    PubMed     Abstract available

  70. SHIGETA S, Shida M, Nagase S, Ikeda M, et al
    Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee project.
    Gynecol Oncol. 2020 Jul 25. pii: S0090-8258(20)33658.
    PubMed     Abstract available

  71. ARA R, Khatun S, Pervin S, Jahan M, et al
    Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.
    Gynecol Oncol. 2020 Jul 14. pii: S0090-8258(20)32322.
    PubMed     Abstract available

  72. CASARIN J, Buda A, Bogani G, Fanfani F, et al
    Predictors of recurrence following laparoscopic radical hysterectomy for early-stage cervical cancer: A multi-institutional study.
    Gynecol Oncol. 2020 Jul 11. pii: S0090-8258(20)32334.
    PubMed     Abstract available

  73. MARTELL K, McIntyre JB, Kornaga EN, Chan AMY, et al
    PIK3CA mutation and CNV status and post-chemoradiotherapy survival in patients with cervical cancer.
    Gynecol Oncol. 2020 Jul 9. pii: S0090-8258(20)32332.
    PubMed     Abstract available

  74. HUH WK, Brady WE, Fracasso PM, Dizon DS, et al
    Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
    Gynecol Oncol. 2020 Jul 5. pii: S0090-8258(20)32317.
    PubMed     Abstract available

    June 2020
  75. BONAZZOLI E, Bellone S, Zammataro L, Gnutti B, et al
    Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
    Gynecol Oncol. 2020 Jun 26. pii: S0090-8258(20)32299.
    PubMed     Abstract available

  76. BALAYA V, Guani B, Benoit L, Magaud L, et al
    Diagnostic value of frozen section examination of sentinel lymph nodes in early-stage cervical cancer at the time of ultrastaging.
    Gynecol Oncol. 2020 Jun 25. pii: S0090-8258(20)31128.
    PubMed     Abstract available

  77. SUTARIA T, Sparks AD, Rao YJ, Lopez-Acevedo M, et al
    Trends in guideline-adherent fertility-sparing surgery for early-stage cervical cancer before and after the Affordable Care Act.
    Gynecol Oncol. 2020 Jun 11. pii: S0090-8258(20)31096.
    PubMed     Abstract available

  78. LI X, Xia L, Chen X, Fu Y, et al
    Simple conization and pelvic lymphadenectomy in early-stage cervical cancer: A retrospective analysis and review of the literature.
    Gynecol Oncol. 2020 Jun 6. pii: S0090-8258(20)31120.
    PubMed     Abstract available

  79. TU H, Gu HF, Huang H, Liu KJ, et al
    Sectioning protocol determines accuracy of intraoperative pathological examination of sentinel lymph node in cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2020 Jun 4. pii: S0090-8258(20)31122.
    PubMed     Abstract available

  80. LIU P, Liang C, Lu A, Chen X, et al
    Risk factors and long-term impact of urologic complications during radical hysterectomy for cervical cancer in China, 2004-2016.
    Gynecol Oncol. 2020 Jun 2. pii: S0090-8258(20)31098.
    PubMed     Abstract available

  81. VASSEUR D, Lopez J, Croce S, Tondeur G, et al
    Transcriptome profiling of gastric-type endocervical adenocarcinomas identifies key signaling pathways for tumor progression.
    Gynecol Oncol. 2020;157:775-782.
    PubMed     Abstract available

    May 2020
  82. MATSUO K, Matsuzaki S, Mandelbaum RS, Chang EJ, et al
    Minimally invasive radical hysterectomy for early-stage cervical cancer: Volume-outcome relationship in the early experience period.
    Gynecol Oncol. 2020 May 27. pii: S0090-8258(20)31077.
    PubMed     Abstract available

  83. HE F, Li W, Liu P, Kang S, et al
    Influence of uterine corpus invasion on prognosis in stage IA2-IIB cervical cancer: A multicenter retrospective cohort study.
    Gynecol Oncol. 2020 May 26. pii: S0090-8258(20)31072.
    PubMed     Abstract available

  84. DIAZ-FEIJOO B, Franco S, Torne A, Benito V, et al
    Implications of extraperitoneal paraaortic lymphadenectomy to the left renal vein in locally advanced cervical cancer. A Spanish multicenter study.
    Gynecol Oncol. 2020 May 26. pii: S0090-8258(20)31071.
    PubMed     Abstract available

  85. ZYLA RE, Gien LT, Vicus D, Olkhov-Mitsel E, et al
    The prognostic role of horizontal and circumferential tumor extent in cervical cancer: Implications for the 2019 FIGO staging system.
    Gynecol Oncol. 2020 May 26. pii: S0090-8258(20)31084.
    PubMed     Abstract available

  86. SILVA SR, Gaskins JT, Nichols MR, Metzinger DS, et al
    Cervical cancer incidence and mortality rates in Kentucky.
    Gynecol Oncol. 2020 May 23. pii: S0090-8258(20)31079.
    PubMed     Abstract available

  87. MATSUO K, Novatt H, Matsuzaki S, Hom MS, et al
    Wait-time for hysterectomy and survival of women with early-stage cervical cancer: A clinical implication during the coronavirus pandemic.
    Gynecol Oncol. 2020 May 18. pii: S0090-8258(20)31087.
    PubMed     Abstract available

  88. WENZEL HHB, Van Kol KGG, Nijman HW, Lemmens VEPP, et al
    Cervical cancer with </=5 mm depth of invasion and >7 mm horizontal spread - Is lymph node assessment only required in patients with LVSI?
    Gynecol Oncol. 2020 May 4. pii: S0090-8258(20)31015.
    PubMed     Abstract available

    April 2020
  89. GULTEKIN M, Dundar S, Keskinkilic B, Turkyilmaz M, et al
    How to triage HPV positive cases: Results of four million females.
    Gynecol Oncol. 2020 Apr 30. pii: S0090-8258(20)31008.
    PubMed     Abstract available

  90. CHEN Y, Li G
    Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak.
    Gynecol Oncol. 2020 Apr 29. pii: S0090-8258(20)31019.

  91. REICH O, Regauer S, Kashofer K
    Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.
    Gynecol Oncol. 2020 Apr 27. pii: S0090-8258(20)30985.
    PubMed     Abstract available

  92. GRIGSBY PW, Massad LS, Mutch DG, Powell MA, et al
    FIGO 2018 staging criteria for cervical cancer: Impact on stage migration and survival.
    Gynecol Oncol. 2020 Apr 2. pii: S0090-8258(20)30252.
    PubMed     Abstract available

    March 2020
  93. MIGNOT F, Gouy S, Schernberg A, Bockel S, et al
    Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy.
    Gynecol Oncol. 2020 Mar 13. pii: S0090-8258(20)30222.
    PubMed     Abstract available

  94. SUN Z, Huang B, Liu C, Yang Y, et al
    Comparison of neoadjuvant treatments followed by radical surgery or chemoradiation on quality of life in patients with stage IB2-IIA cervical cancer.
    Gynecol Oncol. 2020 Mar 12. pii: S0090-8258(20)30092.
    PubMed     Abstract available

  95. KIM H, Cho WK, Kim YJ, Kim YS, et al
    Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy.
    Gynecol Oncol. 2020 Mar 2. pii: S0090-8258(20)30177.
    PubMed     Abstract available

  96. HU SY, Rezhake R, Chen F, Zhang X, et al
    Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China.
    Gynecol Oncol. 2020;156:616-623.
    PubMed     Abstract available

  97. LEE H, Choi M, Jo M, Park EY, et al
    Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
    Gynecol Oncol. 2020;156:641-646.
    PubMed     Abstract available

  98. ZONG L, Zhang Q, Kong Y, Yang F, et al
    The tumor-stroma ratio is an independent predictor of survival in patients with 2018 FIGO stage IIIC squamous cell carcinoma of the cervix following primary radical surgery.
    Gynecol Oncol. 2020;156:676-681.
    PubMed     Abstract available

    February 2020
  99. LI X, Xia L, Li J, Chen X, et al
    Reproductive and obstetric outcomes after abdominal radical trachelectomy (ART) for patients with early-stage cervical cancers in Fudan, China.
    Gynecol Oncol. 2020 Feb 28. pii: S0090-8258(20)30152.
    PubMed     Abstract available

  100. CHOI CH, Chung JY, Kang JH, Paik ES, et al
    Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2020 Feb 24. pii: S0090-8258(20)30153.
    PubMed     Abstract available

  101. AVIKI EM, Chen L, Dessources K, Leitao MM Jr, et al
    Impact of hospital volume on surgical management and outcomes for early-stage cervical cancer.
    Gynecol Oncol. 2020 Feb 21. pii: S0090-8258(20)30165.
    PubMed     Abstract available

  102. CHARO LM, Vaida F, Eskander RN, Binder P, et al
    Rapid dissemination of practice-changing information: A longitudinal analysis of real-world rates of minimally invasive radical hysterectomy before and after presentation of the LACC trial.
    Gynecol Oncol. 2020 Feb 17. pii: S0090-8258(20)30154.
    PubMed     Abstract available

  103. CHEN B, Ji M, Li P, Liu P, et al
    Comparison between robot-assisted radical hysterectomy and abdominal radical hysterectomy for cervical cancer: A multicentre retrospective study.
    Gynecol Oncol. 2020 Feb 14. pii: S0090-8258(20)30155.
    PubMed     Abstract available

  104. DILLEY S, Miller KM, Huh WK
    Human papillomavirus vaccination: Ongoing challenges and future directions.
    Gynecol Oncol. 2020;156:498-502.
    PubMed     Abstract available

    January 2020
  105. MATERN T, Kang E, Lim PC
    Factors in the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma.
    Gynecol Oncol. 2020 Jan 30. pii: S0090-8258(20)30081.
    PubMed     Abstract available

  106. TRIMBLE CL, Levinson K, Maldonado L, Donovan MJ, et al
    A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
    Gynecol Oncol. 2020 Jan 28. pii: S0090-8258(19)31865.
    PubMed     Abstract available

  107. JORDAN SE, Schlumbrecht M, George S, Pearson JM, et al
    The Moore Criteria: Applicability in a diverse, non-trial, recurrent cervical cancer population.
    Gynecol Oncol. 2020 Jan 23. pii: S0090-8258(20)30001.
    PubMed     Abstract available

  108. MATSUO K, Matsuzaki S, Mandelbaum RS, Matsushima K, et al
    Association between hospital surgical volume and perioperative outcomes of fertility-sparing trachelectomy for cervical cancer: A national study in the United States.
    Gynecol Oncol. 2020 Jan 22. pii: S0090-8258(20)30021.
    PubMed     Abstract available

  109. LOOPIK DL, IntHout J, Ebisch RMF, Melchers WJG, et al
    The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women.
    Gynecol Oncol. 2020 Jan 20. pii: S0090-8258(20)30067.
    PubMed     Abstract available

  110. LI T, Wu Z, Jiang M, Zhao Y, et al
    Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women.
    Gynecol Oncol. 2020 Jan 18. pii: S0090-8258(20)30022.
    PubMed     Abstract available

  111. PUROHIT S, Ferris DG, Alvarez M, Tran PMH, et al
    Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy.
    Gynecol Oncol. 2020 Jan 16. pii: S0090-8258(20)30023.
    PubMed     Abstract available

  112. MERIDETH MA, Harney LA, Vyas N, Bachi A, et al
    Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
    Gynecol Oncol. 2020 Jan 15. pii: S0090-8258(19)31867.
    PubMed     Abstract available

  113. BRANDT B, Sioulas V, Basaran D, Kuhn T, et al
    Minimally invasive surgery versus laparotomy for radical hysterectomy in the management of early-stage cervical cancer: Survival outcomes.
    Gynecol Oncol. 2020 Jan 7. pii: S0090-8258(19)31868.
    PubMed     Abstract available

  114. SANTIN AD, Deng W, Frumovitz M, Buza N, et al
    Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002).
    Gynecol Oncol. 2020 Jan 7. pii: S0090-8258(19)31864.
    PubMed     Abstract available

  115. SCHAD MD, Patel AK, Glaser SM, Balasubramani GK, et al
    Declining brachytherapy utilization for cervical cancer patients - Have we reversed the trend?
    Gynecol Oncol. 2020 Jan 7. pii: S0090-8258(19)31863.
    PubMed     Abstract available

    December 2019
  116. CLARK KT, Trimble CL
    Current status of therapeutic HPV vaccines.
    Gynecol Oncol. 2019 Dec 20. pii: S0090-8258(19)31838.
    PubMed     Abstract available

  117. VARELA CAGETTI L, Zemmour C, Minsat M, Lambaudie E, et al
    Lessons from radiochemotherapy and modern image-guided adaptive brachytherapy followed by hysterectomy.
    Gynecol Oncol. 2019 Dec 18. pii: S0090-8258(19)31785.
    PubMed     Abstract available

  118. YANG J, Delara R, Magrina J, Magtibay P, et al
    Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: A propensity score-matched analysis.
    Gynecol Oncol. 2019 Dec 13. pii: S0090-8258(19)31801.
    PubMed     Abstract available

  119. BALAYA V, Bresset A, Guani B, Magaud L, et al
    Risk factors for failure of bilateral sentinel lymph node mapping in early-stage cervical cancer.
    Gynecol Oncol. 2019 Dec 12. pii: S0090-8258(19)31614.
    PubMed     Abstract available

  120. PERKINS V, Moore K, Vesely S, Matsuo K, et al
    Incorporation of whole pelvic radiation into treatment of stage IVB cervical cancer: A novel treatment strategy.
    Gynecol Oncol. 2019 Dec 3. pii: S0090-8258(19)31620.
    PubMed     Abstract available

  121. LIANG C, Liu P, Cui Z, Liang Z, et al
    Effect of laparoscopic versus abdominal radical hysterectomy on major surgical complications in women with stage IA-IIB cervical cancer in China, 2004-2015.
    Gynecol Oncol. 2019 Dec 2. pii: S0090-8258(19)31619.
    PubMed     Abstract available

    November 2019
  122. LUHRS O, Ekdahl L, Lonnerfors C, Geppert B, et al
    Combining Indocyanine Green and Tc(99)-nanocolloid does not increase the detection rate of sentinel lymph nodes in early stage cervical cancer compared to Indocyanine Green alone.
    Gynecol Oncol. 2019 Nov 26. pii: S0090-8258(19)31677.
    PubMed     Abstract available

  123. MACHIDA H, Iwata T, Okugawa K, Matsuo K, et al
    Fertility-sparing trachelectomy for early-stage cervical cancer: A proposal of an ideal candidate.
    Gynecol Oncol. 2019 Nov 23. pii: S0090-8258(19)31672.
    PubMed     Abstract available

  124. HIROSE S, Murakami N, Takahashi K, Kuno I, et al
    Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
    Gynecol Oncol. 2019 Nov 19. pii: S0090-8258(19)31606.
    PubMed     Abstract available

  125. MCCOMAS KN, Torgeson AM, Ager BJ, Hellekson C, et al
    The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.
    Gynecol Oncol. 2019 Nov 16. pii: S0090-8258(19)31609.
    PubMed     Abstract available

  126. WORMALD BW, Doran SJ, Ind TE, D'Arcy J, et al
    Radiomic features of cervical cancer on T2-and diffusion-weighted MRI: Prognostic value in low-volume tumors suitable for trachelectomy.
    Gynecol Oncol. 2019 Nov 1. pii: S0090-8258(19)31567.
    PubMed     Abstract available

  127. MALAGON T, Louvanto K, Ramanakumar AV, Koushik A, et al
    Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.
    Gynecol Oncol. 2019;155:245-253.
    PubMed     Abstract available

  128. WANG W, Liu X, Hou X, Lian X, et al
    Posttreatment squamous cell carcinoma antigen predicts treatment failure in patients with cervical squamous cell carcinoma treated with concurrent chemoradiotherapy.
    Gynecol Oncol. 2019;155:224-228.
    PubMed     Abstract available

    October 2019
  129. ISHIKAWA M, Kasamatsu T, Tsuda H, Fukunaga M, et al
    A multi-center retrospective study of neuroendocrine tumors of the uterine cervix: Prognosis according to the new 2018 staging system, comparing outcomes for different chemotherapeutic regimens and histopathological subtypes.
    Gynecol Oncol. 2019 Oct 18. pii: S0090-8258(19)31540.
    PubMed     Abstract available

  130. VAN KOL KGG, Vergeldt TFM, Bekkers RLM
    Abdominal radical trachelectomy versus chemotherapy followed by vaginal radical trachelectomy in stage 1B2 (FIGO 2018) cervical cancer. A systematic review on fertility and recurrence rates.
    Gynecol Oncol. 2019 Oct 9. pii: S0090-8258(19)31546.
    PubMed     Abstract available

  131. WU P, Xiong H, Yang M, Li L, et al
    Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31560.
    PubMed     Abstract available

  132. GULERIA C, Suri V, Kapoor R, Minz RW, et al
    Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
    Gynecol Oncol. 2019;155:151-160.
    PubMed     Abstract available

    September 2019
  133. SIMS TT, Colbert LE, Zheng J, Delgado Medrano AY, et al
    Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
    Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31489.
    PubMed     Abstract available

  134. PARRA SG, Rodriguez AM, Cherry KD, Schwarz RA, et al
    Low-cost, high-resolution imaging for detecting cervical precancer in medically-underserved areas of Texas.
    Gynecol Oncol. 2019;154:558-564.
    PubMed     Abstract available

    August 2019
  135. BJURBERG M, Holmberg E, Borgfeldt C, Floter-Radestad A, et al
    Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31474.
    PubMed     Abstract available

  136. RADER JS, Pan A, Corbin B, Iden M, et al
    Identification and validation of a prognostic proteomic signature for cervical cancer.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31473.
    PubMed     Abstract available

  137. HIRAO N, Iwata T, Tanaka K, Nishio H, et al
    Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31478.
    PubMed     Abstract available

  138. SHUKLA V, Varghese VK, Kabekkodu SP, Mallya S, et al
    Enumeration of deregulated miRNAs in liquid and tissue biopsies of cervical cancer.
    Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31463.
    PubMed     Abstract available

  139. BIANCHI A, Lopez S, Altwerger G, Bellone S, et al
    PARP-1 activity (PAR) determines the sensitivity of cervical cancer to olaparib.
    Gynecol Oncol. 2019 Aug 18. pii: S0090-8258(19)31461.
    PubMed     Abstract available

  140. KIM SI, Lee M, Lee S, Suh DH, et al
    Impact of laparoscopic radical hysterectomy on survival outcome in patients with FIGO stage IB cervical cancer: A matching study of two institutional hospitals in Korea.
    Gynecol Oncol. 2019 Aug 2. pii: S0090-8258(19)31408.
    PubMed     Abstract available

    July 2019
  141. LIU B, Li L, Wang M, Wei L, et al
    Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
    Gynecol Oncol. 2019 Jul 12. pii: S0090-8258(19)31354.
    PubMed     Abstract available

  142. ALIMENA S, Yang DD, Melamed A, Mahal BA, et al
    Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Gynecol Oncol. 2019 Jul 7. pii: S0090-8258(19)31338.
    PubMed     Abstract available

  143. SUZUKI K, Nagao S, Shibutani T, Yamamoto K, et al
    Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
    Gynecol Oncol. 2019 Jul 5. pii: S0090-8258(19)31262.
    PubMed     Abstract available

  144. PAIK ES, Lim MC, Kim MH, Kim YH, et al
    Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Gynecol Oncol. 2019 Jul 1. pii: S0090-8258(19)31339.
    PubMed     Abstract available

    June 2019
  145. LI W, Meng Y, Wang Y, Cheng X, et al
    Association of age and viral factors with high-risk HPV persistence: A retrospective follow-up study.
    Gynecol Oncol. 2019 Jun 24. pii: S0090-8258(19)31270.
    PubMed     Abstract available

  146. DOTTINO JA, He W, Sun CC, Zhao H, et al
    Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes.
    Gynecol Oncol. 2019 Jun 14. pii: S0090-8258(19)31280.
    PubMed     Abstract available

  147. DICK S, Kremer WW, De Strooper LMA, Lissenberg-Witte BI, et al
    Long-term CIN3+ risk of HPV positive women after triage with FAM19A4/miR124-2 methylation analysis.
    Gynecol Oncol. 2019 Jun 7. pii: S0090-8258(19)31279.
    PubMed     Abstract available

  148. WILLOWS K, Kupets R, Diong C, Vicus D, et al
    Rates over time and regional variation of radical minimally invasive surgery for cervical cancer: A population based study.
    Gynecol Oncol. 2019 Jun 3. pii: S0090-8258(19)31263.
    PubMed     Abstract available

  149. GUAN Y, Luan Y, Xie Y, Zhou H, et al
    Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
    Gynecol Oncol. 2019;153:661-669.
    PubMed     Abstract available

    May 2019
  150. LIU JF, Gray KP, Wright AA, Campos S, et al
    Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer.
    Gynecol Oncol. 2019 May 20. pii: S0090-8258(19)31228.
    PubMed     Abstract available

  151. GIL KM, Pugh SL, Klopp AH, Yeung AR, et al
    Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
    Gynecol Oncol. 2019 May 16. pii: S0090-8258(19)31184.
    PubMed     Abstract available

  152. ANDERSEN B, Christensen BS, Christensen J, Ejersbo D, et al
    HPV-prevalence in elderly women in Denmark.
    Gynecol Oncol. 2019 May 11. pii: S0090-8258(19)31182.
    PubMed     Abstract available

    April 2019
  153. ENGLISH DP, Huang M
    Highlights from the Society of Gynecologic Oncology's 50th Annual Meeting on Women's Cancer.
    Gynecol Oncol. 2019 Apr 22. pii: S0090-8258(19)31150.

  154. MA S, Wang J, Han Y, Guo F, et al
    Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Gynecol Oncol. 2019 Apr 18. pii: S0090-8258(19)30508.
    PubMed     Abstract available

  155. BOGANI G, Chiappa V, Vinti D, Somigliana E, et al
    Long-term results of fertility-sparing treatment for early-stage cervical cancer.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30502.
    PubMed     Abstract available

  156. BALAYA V, Mathevet P, Magaud L, Bonsang-Kitzis H, et al
    Predictive factors of unexpected lymphatic drainage pathways in early-stage cervical cancer.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)30503.
    PubMed     Abstract available

  157. LUCIDO CT, Wynja E, Madeo M, Williamson CS, et al
    Innervation of cervical carcinoma is mediated by cancer-derived exosomes.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)31149.
    PubMed     Abstract available

  158. SWAILES AL, Hossler CE, Kesterson JP
    Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present day.
    Gynecol Oncol. 2019 Apr 14. pii: S0090-8258(19)30499.
    PubMed     Abstract available

  159. PIGNATA S, Scambia G, Lorusso D, De Giorgi U, et al
    The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
    Gynecol Oncol. 2019 Apr 9. pii: S0090-8258(19)30495.
    PubMed     Abstract available

  160. HORSBOEL TA, Kjaer SK, Johansen C, Suppli NP, et al
    Increased risk for depression persists for years among women treated for gynecological cancers - a register-based cohort study with up to 19years of follow-up.
    Gynecol Oncol. 2019 Apr 8. pii: S0090-8258(19)30494.
    PubMed     Abstract available

  161. HARPER DM, Nieminen P, Donders G, Einstein MH, et al
    The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5years of follow-up.
    Gynecol Oncol. 2019 Apr 2. pii: S0090-8258(19)30484.
    PubMed     Abstract available

    The change in landscape after a new landmark is constructed: Radical hysterectomy for early cervical cancer and Minimally Invasive Surgery.
    Gynecol Oncol. 2019;153:1-2.

    March 2019
  163. LIN AJ, Ma S, Markovina S, Schwarz J, et al
    Clinical outcomes after isolated pelvic failure in cervical cancer patients treated with definitive radiation.
    Gynecol Oncol. 2019 Mar 21. pii: S0090-8258(19)30297.
    PubMed     Abstract available

  164. RUENGKHACHORN I, Phithakwatchara N, Viriyapak B, Sangkarat S, et al
    Comparison of oncologic outcomes of unanticipated cervical carcinoma in women undergoing inadvertent simple hysterectomy and those undergoing surgical treatment after preoperative diagnosis.
    Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30135.
    PubMed     Abstract available

  165. WRIGHT TC JR, Parvu V, Stoler MH, Kodsi S, et al
    HPV infections and cytologic abnormalities in vaccinated women 21-34years of age: Results from the baseline phase of the Onclarity trial.
    Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30126.
    PubMed     Abstract available

  166. DOO DW, Kirkland CT, Griswold LH, McGwin G, et al
    Comparative outcomes between robotic and abdominal radical hysterectomy for IB1 cervical cancer: Results from a single high volume institution.
    Gynecol Oncol. 2019 Mar 6. pii: S0090-8258(19)30149.
    PubMed     Abstract available

  167. CALO C, Elliott JO, Clements A, Reid G, et al
    Cervical cancer radiation therapy compliance rates based on location of radiation therapy.
    Gynecol Oncol. 2019;152:528-532.
    PubMed     Abstract available

  168. VELENTZIS LS, Smith MA, Simms KT, Lew JB, et al
    Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
    Gynecol Oncol. 2019;152:465-471.
    PubMed     Abstract available

  169. HALL MT, Smith MA, Lew JB, O'Hallahan J, et al
    The combined impact of implementing HPV immunisation and primary HPV screening in New Zealand: Transitional and long-term benefits, costs and resource utilisation implications.
    Gynecol Oncol. 2019;152:472-479.
    PubMed     Abstract available

  170. SHEU J, Palileo A, Chen MY, Hoepner L, et al
    Hospice utilization in advanced cervical malignancies: An analysis of the National Inpatient Sample.
    Gynecol Oncol. 2019;152:594-598.
    PubMed     Abstract available

    February 2019
  171. EINSTEIN MH, Ndlovu N, Lee J, Stier EA, et al
    Cisplatin and radiation therapy in HIV-positive women with locally advanced cervical cancer in sub-Saharan Africa: A phase II study of the AIDS malignancy consortium.
    Gynecol Oncol. 2019 Feb 15. pii: S0090-8258(19)30065.
    PubMed     Abstract available

  172. LIANG J, Wolsiefer K, Zestcott CA, Chase D, et al
    Implicit bias toward cervical cancer: Provider and training differences.
    Gynecol Oncol. 2019 Feb 7. pii: S0090-8258(19)30055.
    PubMed     Abstract available

  173. HUTCHCRAFT ML, Smith B, McLaughlin EM, Hade EM, et al
    Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.
    Gynecol Oncol. 2019 Feb 2. pii: S0090-8258(19)30068.
    PubMed     Abstract available

  174. VASSILAKOS P, Poncet A, Catarino R, Viviano M, et al
    Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.
    Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30064.
    PubMed     Abstract available

  175. XIA P, Huang M, Zhang Y, Xiong X, et al
    NCK1 promotes the angiogenesis of cervical squamous carcinoma via Rac1/PAK1/MMP2 signal pathway.
    Gynecol Oncol. 2019;152:387-395.
    PubMed     Abstract available

    January 2019
  176. NISHIO S, Mikami Y, Tokunaga H, Yaegashi N, et al
    Analysis of gastric-type mucinous carcinoma of the uterine cervix - An aggressive tumor with a poor prognosis: A multi-institutional study.
    Gynecol Oncol. 2019 Jan 29. pii: S0090-8258(19)30063.
    PubMed     Abstract available

  177. HOLSCHNEIDER CH, Petereit DG, Chu C, Hsu IC, et al
    Brachytherapy: A critical component of primary radiation therapy for cervical cancer: For the Society of Gynecologic Oncology (SGO) and the American Brachytherapy Society (ABS).
    Gynecol Oncol. 2019 Jan 17. pii: S0090-8258(18)31297.
    PubMed     Abstract available

  178. KIM SI, Cho JH, Seol A, Kim YI, et al
    Comparison of survival outcomes between minimally invasive surgery and conventional open surgery for radical hysterectomy as primary treatment in patients with stage IB1-IIA2 cervical cancer.
    Gynecol Oncol. 2019 Jan 11. pii: S0090-8258(19)30041.
    PubMed     Abstract available

  179. STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
    Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, >/=25years of age, with NILM cytology.
    Gynecol Oncol. 2019 Jan 9. pii: S0090-8258(18)31538.
    PubMed     Abstract available

  180. WANG J, Du Y, Dong J, Zhou Y, et al
    Clinical significance of genotyping for human papillomavirus (HPV) 16 18/45 combined with cytology in cervical exfoliated cells in HPV oncogenic mRNA-positive women.
    Gynecol Oncol. 2019 Jan 7. pii: S0090-8258(18)31542.
    PubMed     Abstract available

  181. LOOPIK DL, Bekkers RLM, Massuger LFAG, Melchers WJG, et al
    Justifying conservative management of CIN2 in women younger than 25years - A population-based study.
    Gynecol Oncol. 2019;152:82-86.
    PubMed     Abstract available

    December 2018
  182. ZHANG L, Jiang Y, Lu X, Zhao H, et al
    Genomic characterization of cervical cancer based on human papillomavirus status.
    Gynecol Oncol. 2018 Dec 20. pii: S0090-8258(18)31516.
    PubMed     Abstract available

  183. GAFFNEY DK, Hashibe M, Kepka D, Maurer KA, et al
    Too many women are dying from cervix cancer: Problems and solutions.
    Gynecol Oncol. 2018;151:547-554.
    PubMed     Abstract available

    November 2018
  184. ZHU B, Pan Y, Zheng X, Zhang Q, et al
    A clinical, biologic and mechanistic analysis of the role of ZNF692 in cervical cancer.
    Gynecol Oncol. 2018 Nov 19. pii: S0090-8258(18)31423.
    PubMed     Abstract available

  185. SIN STK, Li Y, Liu M, Ma S, et al
    TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling.
    Gynecol Oncol. 2018 Nov 12. pii: S0090-8258(18)31354.
    PubMed     Abstract available

  186. SPEES LP, Wheeler SB, Varia M, Weinberger M, et al
    Evaluating the urban-rural paradox: The complicated relationship between distance and the receipt of guideline-concordant care among cervical cancer patients.
    Gynecol Oncol. 2018 Nov 12. pii: S0090-8258(18)31407.
    PubMed     Abstract available

  187. UPPAL S, Rebecca Liu J, Kevin Reynolds R, Rice LW, et al
    Trends and comparative effectiveness of inpatient radical hysterectomy for cervical cancer in the United States (2012-2015).
    Gynecol Oncol. 2018 Nov 10. pii: S0090-8258(18)31246.
    PubMed     Abstract available

  188. LEEMAN A, Ebisch RMF, Kasius A, Bosgraaf RP, et al
    Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation.
    Gynecol Oncol. 2018;151:311-318.
    PubMed     Abstract available

  189. FIANO V, Trevisan M, Fasanelli F, Grasso C, et al
    Methylation in host and viral genes as marker of aggressiveness in cervical lesions: Analysis in 543 unscreened women.
    Gynecol Oncol. 2018;151:319-326.
    PubMed     Abstract available

  190. SPAANS VM, Scheunhage DA, Barzaghi B, de Kroon CD, et al
    Independent validation of the prognostic significance of invasion patterns in endocervical adenocarcinoma: Pattern A predicts excellent survival.
    Gynecol Oncol. 2018;151:196-201.
    PubMed     Abstract available

    October 2018
  191. MATSUO K, Machida H, Mandelbaum RS, Konishi I, et al
    Validation of the 2018 FIGO cervical cancer staging system.
    Gynecol Oncol. 2018 Oct 30. pii: S0090-8258(18)31309.
    PubMed     Abstract available

  192. CIBULA D, Abu-Rustum NR, Fischerova D, Pather S, et al
    Surgical treatment of "intermediate risk" lymph node negative cervical cancer patients without adjuvant radiotherapy-A retrospective cohort study and review of the literature.
    Gynecol Oncol. 2018 Oct 20. pii: S0090-8258(18)31298.
    PubMed     Abstract available

  193. HUANG C, Lu H, Li J, Xie X, et al
    SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway.
    Gynecol Oncol. 2018 Oct 15. pii: S0090-8258(18)31284.
    PubMed     Abstract available

  194. SAPIENZA LG, Jhingran A, Kollmeier MA, Lin LL, et al
    Decrease in uterine perforations with ultrasound image-guided applicator insertion in intracavitary brachytherapy for cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2018 Oct 14. pii: S0090-8258(18)31290.
    PubMed     Abstract available

  195. CIBULA D, McCluggage WG
    Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions.
    Gynecol Oncol. 2018 Oct 11. pii: S0090-8258(18)31286.
    PubMed     Abstract available

  196. MARTINEZ-GOMEZ C, Angeles MA, Martinez A, Ferron G, et al
    Creation of a Miami Pouch in 10 logical steps.
    Gynecol Oncol. 2018;151:178-179.

  197. RODRIGUES LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, et al
    Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajos region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factors.
    Gynecol Oncol. 2018;151:102-110.
    PubMed     Abstract available

    September 2018
  198. ZHANG L, Xu XQ, Hu SY, Chen F, et al
    Durability of clinical performance afforded by self-collected HPV testing: A 15-year cohort study in China.
    Gynecol Oncol. 2018 Sep 27. pii: S0090-8258(18)31231.
    PubMed     Abstract available

  199. WANG W, Zhang F, Hu K, Hou X, et al
    Image-guided, intensity-modulated radiation therapy in definitive radiotherapy for 1433 patients with cervical cancer.
    Gynecol Oncol. 2018 Sep 25. pii: S0090-8258(18)31243.
    PubMed     Abstract available

  200. MATSUO K, Machida H, Mandelbaum RS, Ragab OM, et al
    Tumor-specific outcome of metachronous uterine malignancy after pelvic irradiation for cervical cancer.
    Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31165.
    PubMed     Abstract available

  201. GHELARDI A, Parazzini F, Martella F, Pieralli A, et al
    SPERANZA project: HPV vaccination after treatment for CIN2.
    Gynecol Oncol. 2018 Sep 6. pii: S0090-8258(18)31163.

  202. KIM HJ, Chang JS, Koom WS, Lee KC, et al
    Radiotherapy is a safe and effective salvage treatment for recurrent cervical cancer.
    Gynecol Oncol. 2018 Sep 5. pii: S0090-8258(18)31158.
    PubMed     Abstract available

  203. SIMONDS HM, Botha MH, Neugut AI, Van Der Merwe FH, et al
    Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort.
    Gynecol Oncol. 2018 Sep 4. pii: S0090-8258(18)31168.
    PubMed     Abstract available

  204. DE VINCENZO R, Tortorella L, Ricci C, Cavaliere AF, et al
    Locally advanced cervical cancer complicating pregnancy: A case of competing risks from the Catholic University of the Sacred Heart in Rome.
    Gynecol Oncol. 2018;150:398-405.
    PubMed     Abstract available

  205. DEL CARMEN MG, Pareja R, Melamed A, Rodriguez J, et al
    Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
    Gynecol Oncol. 2018;150:406-411.
    PubMed     Abstract available

    August 2018
  206. BOARDMAN CH, Brady WE, Dizon DS, Kunos CA, et al
    A Phase I Evaluation of Extended Field Radiation Therapy With Concomitant Cisplatin Chemotherapy Followed by Paclitaxel and Carboplatin Chemotherapy in Women With Cervical Carcinoma Metastatic to the Para-aortic Lymph Nodes: An NRG Oncology/Gynecologi
    Gynecol Oncol. 2018 Aug 31. pii: S0090-8258(18)31095.
    PubMed     Abstract available

  207. WILFORD J, Osann K, Hsieh S, Monk B, et al
    Validation of PROMIS emotional distress short form scales for cervical cancer.
    Gynecol Oncol. 2018 Aug 2. pii: S0090-8258(18)31086.
    PubMed     Abstract available

  208. ANGELES MA, Martinez-Gomez C, Martinez A, Ferron G, et al
    Laparoscopic hand-assisted Miami Pouch after pelvic exenteration in 10 steps.
    Gynecol Oncol. 2018;150:389-390.
    PubMed     Abstract available

    July 2018
  209. MATSUO K, Blake EA, Machida H, Mandelbaum RS, et al
    Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
    Gynecol Oncol. 2018 Jul 24. pii: S0090-8258(18)31080.
    PubMed     Abstract available

  210. TIWARI R, Narayanan GS, Jayakumar V, Narayanan S, et al
    The promise of image-guided brachytherapy of better clinical outcomes in treatment of cervical cancer: Does it deliver? An Indian scenario.
    Gynecol Oncol. 2018 Jul 14. pii: S0090-8258(18)31068.
    PubMed     Abstract available

  211. XUE R, Cai X, Xu H, Wu S, et al
    The efficacy of concurrent weekly carboplatin with radiotherapy in the treatment of cervical cancer: A meta-analysis.
    Gynecol Oncol. 2018 Jul 8. pii: S0090-8258(18)31018.
    PubMed     Abstract available

  212. MARTINEZ-GOMEZ C, Angeles MA, Martinez A, Ferron G, et al
    Laparoscopic anterior pelvic exenteration in 10 steps.
    Gynecol Oncol. 2018;150:201-202.

  213. CHARAKORN C, Thadanipon K, Chaijindaratana S, Rattanasiri S, et al
    The association between serum squamous cell carcinoma antigen and recurrence and survival of patients with cervical squamous cell carcinoma: A systematic review and meta-analysis.
    Gynecol Oncol. 2018;150:190-200.
    PubMed     Abstract available

    June 2018
  214. ROGERI CD, Silveira HCS, Causin RL, Villa LL, et al
    Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Gynecol Oncol. 2018 Jun 27. pii: S0090-8258(18)30990.
    PubMed     Abstract available

  215. LEATH CA 3RD, Monk BJ
    Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years.
    Gynecol Oncol. 2018 Jun 26. pii: S0090-8258(18)31005.
    PubMed     Abstract available

  216. RAUH LA, Saks EJ, Nakad-Rodriguez D, Showalter TN, et al
    Cervical cancer care in rural Virginia: The impact of distance from an academic medical center on outcomes & the role of non-specialized radiation centers.
    Gynecol Oncol. 2018 Jun 20. pii: S0090-8258(18)31001.
    PubMed     Abstract available

  217. STOLER MH, Wright TC Jr, Parvu V, Vaughan L, et al
    The Onclarity Human Papillomavirus Trial: Design, methods, and baseline results.
    Gynecol Oncol. 2018;149:498-505.
    PubMed     Abstract available

    May 2018
  218. STOLNICU S, Barsan I, Hoang L, Patel P, et al
    Stromal invasion pattern identifies patients at lowest risk of lymph node metastasis in HPV-associated endocervical adenocarcinomas, but is irrelevant in adenocarcinomas unassociated with HPV.
    Gynecol Oncol. 2018 May 30. pii: S0090-8258(18)30848.
    PubMed     Abstract available

  219. YAGUR Y, Weitzner O, Gemer O, Lavie O, et al
    Postoperative radiation rates in stage IIA1 cervical cancer: Is surgical treatment justified? An Israeli Gynecologic Oncology Group Study.
    Gynecol Oncol. 2018 May 25. pii: S0090-8258(18)30903.
    PubMed     Abstract available

  220. SALVO G, Frumovitz M, Pareja R, Lee J, et al
    Simple trachelectomy with pelvic lymphadenectomy as a viable treatment option in pregnant patients with stage IB1 (>/=2cm) cervical cancer: Bridging the gap to fetal viability.
    Gynecol Oncol. 2018 May 24. pii: S0090-8258(18)30908.
    PubMed     Abstract available

  221. BAIOCCHI G, Mantoan H, Chen MJ, Faloppa CC, et al
    Uterine transposition after radical trachelectomy.
    Gynecol Oncol. 2018 May 23. pii: S0090-8258(18)30896.

  222. PHILP L, Jembere N, Wang L, Gao J, et al
    Pap tests in the diagnosis of cervical cancer: Help or hinder?
    Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30906.
    PubMed     Abstract available

  223. TSENG JH, Aloisi A, Sonoda Y, Gardner GJ, et al
    Less versus more radical surgery in stage IB1 cervical cancer: A population-based study of long-term survival.
    Gynecol Oncol. 2018 May 15. pii: S0090-8258(18)30849.
    PubMed     Abstract available

  224. DAVIS M, Strickland K, Easter SR, Worley M Jr, et al
    The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts.
    Gynecol Oncol. 2018 May 8. pii: S0090-8258(18)30887.
    PubMed     Abstract available

    Towards identifying new therapeutic targets in cancers attributable to HPV.
    Gynecol Oncol. 2018;149:225-226.

    April 2018
  226. MAYADEV J, Klapheke A, Yashar C, Hsu IC, et al
    Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
    Gynecol Oncol. 2018 Apr 27. pii: S0090-8258(18)30841.
    PubMed     Abstract available

  227. EL-ZEIN M, Bouten S, Louvanto K, Gilbert L, et al
    Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
    Gynecol Oncol. 2018 Apr 17. pii: S0090-8258(18)30274.
    PubMed     Abstract available

  228. MATODA M, Takeshima N, Michimae H, Iwata T, et al
    Postoperative chemotherapy for node-positive cervical cancer: Results of a multicenter phase II trial (JGOG1067).
    Gynecol Oncol. 2018 Apr 13. pii: S0090-8258(18)30286.
    PubMed     Abstract available

  229. DOCKERY LE, Motwani A, Ding K, Doescher M, et al
    Improving cancer care for American Indians with cervical cancer in the Indian Health Service (IHS) system - Navigation may not be enough.
    Gynecol Oncol. 2018;149:89-92.
    PubMed     Abstract available

  230. HAGOPIAN GS, Lieber M, Dottino PR, Margaret Kemeny M, et al
    The impact of nativity on cervical cancer survival in the public hospital system of Queens, New York.
    Gynecol Oncol. 2018;149:63-69.
    PubMed     Abstract available

  231. RAMEY SJ, Asher D, Kwon D, Ahmed AA, et al
    Delays in definitive cervical cancer treatment: An analysis of disparities and overall survival impact.
    Gynecol Oncol. 2018;149:53-62.
    PubMed     Abstract available

  232. STAPLES JN, Wong MS, Rimel BJ
    An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students.
    Gynecol Oncol. 2018;149:101-105.
    PubMed     Abstract available

  233. MAO X, Qin X, Li L, Zhou J, et al
    A 15-long non-coding RNA signature to improve prognosis prediction of cervical squamous cell carcinoma.
    Gynecol Oncol. 2018;149:181-187.
    PubMed     Abstract available

    March 2018
  234. CUNNINGHAM-ERVES J, Forbes L, Ivankova N, Mayo-Gamble T, et al
    Black mother's intention to vaccinate daughters against HPV: A mixed methods approach to identify opportunities for targeted communication.
    Gynecol Oncol. 2018 Mar 24. pii: S0090-8258(18)30219.
    PubMed     Abstract available

  235. CHEN L, Luan S, Xia B, Liu Y, et al
    Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Gynecol Oncol. 2018 Mar 20. pii: S0090-8258(18)30070.
    PubMed     Abstract available

  236. KANAO H, Aoki Y, Hisa T, Takeshima N, et al
    Laparoscopic laterally extended endopelvic resection (LEER) for cervical carcinoma recurring at the pelvic sidewall after concurrent chemoradiotherapy: Our experience in three cases.
    Gynecol Oncol. 2018 Mar 3. pii: S0090-8258(18)30112.
    PubMed     Abstract available

  237. HARKENRIDER MM, Altoos B, Small W Jr.
    Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Gynecol Oncol. 2018;148:437-438.

  238. MINION LE, Tewari KS
    Cervical cancer - State of the science: From angiogenesis blockade to checkpoint inhibition.
    Gynecol Oncol. 2018;148:609-621.
    PubMed     Abstract available

    February 2018
  239. PAREJA R, Echeverri L, Rendon G, Munsell M, et al
    Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete.
    Gynecol Oncol. 2018 Feb 23. pii: S0090-8258(18)30134.
    PubMed     Abstract available

  240. THARAVICHITKUL E, Chakrabandhu S, Klunklin P, Onchan W, et al
    Intermediate-term results of trans-abdominal ultrasound (TAUS)-guided brachytherapy in cervical cancer.
    Gynecol Oncol. 2018 Feb 2. pii: S0090-8258(18)30047.
    PubMed     Abstract available

  241. KANG WD, Ju UC, Kim SM
    Is human papillomavirus genotype important in predicting disease progression in women with biopsy-proven negative or CIN1 of atypical squamous cell of undetermined significance (ASC-US) cytology?
    Gynecol Oncol. 2018;148:305-310.
    PubMed     Abstract available

    January 2018
  242. DEWDNEY SB, Dancisak AC, Lachance JA, Grendys EC Jr, et al
    Society of Gynecologic Oncology Clinical Outcomes Registry: From small beginnings come great things.
    Gynecol Oncol. 2018 Jan 30. pii: S0090-8258(18)30060.
    PubMed     Abstract available

  243. ZHANG HR, Lai SY, Huang LJ, Zhang ZF, et al
    Myosin 1b promotes cell proliferation, migration, and invasion in cervical cancer.
    Gynecol Oncol. 2018 Jan 27. pii: S0090-8258(18)30065.
    PubMed     Abstract available

  244. DOSTALEK L, Zikan M, Fischerova D, Kocian R, et al
    SLN biopsy in cervical cancer patients with tumors larger than 2cm and 4cm.
    Gynecol Oncol. 2018 Jan 21. pii: S0090-8258(18)30001.
    PubMed     Abstract available

  245. PARK SH, Cheon H, Chong GO, Jeong SY, et al
    Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Gynecol Oncol. 2018 Jan 9. pii: S0090-8258(18)30037.
    PubMed     Abstract available

  246. BACORRO W, Dumas I, Escande A, Gouy S, et al
    Dose-volume effects in pathologic lymph nodes in locally advanced cervical cancer.
    Gynecol Oncol. 2018 Jan 8. pii: S0090-8258(17)31621.
    PubMed     Abstract available

  247. DONG L, Wang MZ, Zhao XL, Feng RM, et al
    Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papillomavirus positive women: A prospective screening cohort study.
    Gynecol Oncol. 2018;148:103-110.
    PubMed     Abstract available

  248. GOROSTIDI M, Villalain C, Ruiz R, Jaunarena I, et al
    Technique for precaval and laterocaval nodes excision at extraperitoneal paraaortic lymphadenectomy.
    Gynecol Oncol. 2018;148:233-234.
    PubMed     Abstract available

    December 2017
  249. XIANG L, Jiang W, Ye S, He T, et al
    ERBB2 mutation: A promising target in non-squamous cervical cancer.
    Gynecol Oncol. 2017 Dec 23. pii: S0090-8258(17)31614.
    PubMed     Abstract available

  250. MONTEALEGRE JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, et al
    Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.
    Gynecol Oncol. 2017 Dec 21. pii: S0090-8258(17)31597.
    PubMed     Abstract available

  251. LEE J, Lin JB, Chang CL, Sun FJ, et al
    Impact of para-aortic recurrence risk-guided intensity-modulated radiotherapy in locally advanced cervical cancer with positive pelvic lymph nodes.
    Gynecol Oncol. 2017 Dec 18. pii: S0090-8258(17)31550.
    PubMed     Abstract available

  252. CASTLE PE, Pierz A, Stoler MH
    A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix.
    Gynecol Oncol. 2017 Dec 13. pii: S0090-8258(17)31548.
    PubMed     Abstract available

  253. DILLEY S, Miller K, Huh W
    HPV vaccination.
    Gynecol Oncol. 2017 Dec 12. pii: S0090-8258(17)31547.

  254. BIZZARRI N, Ghirardi V, Kucukmetin A
    Indocyanine green-assisted parametrial dissection during type C1 radical hysterectomy after sentinel lymph node biopsy in early stage cervical cancer.
    Gynecol Oncol. 2017 Dec 6. pii: S0090-8258(17)31496.
    PubMed     Abstract available

  255. PEI X, Xiang L, Ye S, He T, et al
    Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;147:589-596.
    PubMed     Abstract available

  256. MAHANTSHETTY U, Teni T, Naga P, Hotwani C, et al
    Impact of HPV 16/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - A prospective observational study.
    Gynecol Oncol. 2017 Dec 1. pii: S0090-8258(17)31544.
    PubMed     Abstract available

    November 2017
  257. CHOLLI P, Bradford L, Manga S, Nulah K, et al
    Screening for cervical cancer among HIV-positive and HIV-negative women in Cameroon using simultaneous co-testing with careHPV DNA testing and visual inspection enhanced by digital cervicography: Findings of initial screening and one-year follow-up.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31497.
    PubMed     Abstract available

  258. CHONG GO, Lee YH, Han HS, Lee HJ, et al
    Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
    Gynecol Oncol. 2017 Nov 15. pii: S0090-8258(17)31498.
    PubMed     Abstract available

  259. LIE AK, Trope A, Skare GB, Bjorge T, et al
    HPV genotype profile in a Norwegian cohort with ASC-US and LSIL cytology with three year cumulative risk of high grade cervical neoplasia.
    Gynecol Oncol. 2017 Nov 11. pii: S0090-8258(17)31453.
    PubMed     Abstract available

  260. SPAANS VM, Nyoman Bayu Mahendra I, Purwoto G, Trietsch MD, et al
    The landscape of somatic mutations in Indonesian cervical cancer is predominated by the PI3K pathway.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31369.
    PubMed     Abstract available

  261. ISHIKAWA M, Kasamatsu T, Tsuda H, Fukunaga M, et al
    Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Gynecol Oncol. 2017 Nov 4. pii: S0090-8258(17)31449.
    PubMed     Abstract available

    October 2017
  262. NING MS, Ahobila V, Jhingran A, Stecklein SR, et al
    Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer.
    Gynecol Oncol. 2017 Oct 28. pii: S0090-8258(17)31420.
    PubMed     Abstract available

  263. LEE JH, Lee SW, Kim JR, Kim YS, et al
    Tumour size, volume, and marker expression during radiation therapy can predict survival of cervical cancer patients: a multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Oct 27. pii: S0090-8258(17)31360.
    PubMed     Abstract available

  264. LAAN JJ, van Lonkhuijzen LRCW, van Os RM, Tytgat KM, et al
    Socioeconomic status as an independent risk factor for severe late bowel toxicity after primary radiotherapy for cervical cancer.
    Gynecol Oncol. 2017 Oct 23. pii: S0090-8258(17)31416.
    PubMed     Abstract available

  265. YAMAMOTO K, Nagao S, Suzuki K, Kogiku A, et al
    Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors.
    Gynecol Oncol. 2017 Oct 18. pii: S0090-8258(17)31359.
    PubMed     Abstract available

  266. CHEN BJ, Byrne FL, Takenaka K, Modesitt SC, et al
    Transcriptome landscape of long intergenic non-coding RNAs in endometrial cancer.
    Gynecol Oncol. 2017 Oct 16. pii: S0090-8258(17)31367.
    PubMed     Abstract available

  267. DE LIMA MAP, Neto PJN, Lima LPM, Goncalves Junior J, et al
    Association between Epstein-Barr virus (EBV) and cervical carcinoma: A meta-analysis.
    Gynecol Oncol. 2017 Oct 9. pii: S0090-8258(17)31366.
    PubMed     Abstract available

    September 2017
  268. PHILP L, Covens A, Vicus D, Kupets R, et al
    Feasibility and safety of same-day discharge after laparoscopic radical hysterectomy for cervix cancer.
    Gynecol Oncol. 2017 Sep 28. pii: S0090-8258(17)31350.
    PubMed     Abstract available

  269. MAKKONEN P, Heinavaara S, Sarkeala T, Anttila A, et al
    Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.
    Gynecol Oncol. 2017 Sep 21. pii: S0090-8258(17)31335.
    PubMed     Abstract available

  270. LEE SW, Lee SH, Kim J, Kim YS, et al
    Magnetic resonance imaging during definitive chemoradiotherapy can predict tumor recurrence and patient survival in locally advanced cervical cancer: A multi-institutional retrospective analysis of KROG 16-01.
    Gynecol Oncol. 2017 Sep 18. pii: S0090-8258(17)31265.
    PubMed     Abstract available

  271. RAUH LA, Pannone AF, Cantrell LA
    Hormone replacement therapy after treatment for cervical cancer: Are we adhering to standard of care?
    Gynecol Oncol. 2017 Sep 16. pii: S0090-8258(17)31333.
    PubMed     Abstract available

  272. AZAIS H, Ghesquiere L, Petitnicolas C, Borghesi Y, et al
    Pretherapeutic staging of locally advanced cervical cancer: Inframesenteric paraaortic lymphadenectomy accuracy to detect paraaortic metastases in comparison with infrarenal paraaortic lymphadenectomy.
    Gynecol Oncol. 2017 Sep 14. pii: S0090-8258(17)31334.
    PubMed     Abstract available

  273. HUO D, Anderson D, Palmer JR, Herbst AL, et al
    Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: Update after 40-year follow-up.
    Gynecol Oncol. 2017;146:566-571.
    PubMed     Abstract available

  274. LOPEZ LABROUSSE MI, Frumovitz M, Guadalupe Patrono M, Ramirez PT, et al
    Sentinel lymph node mapping in minimally invasive surgery: Role of imaging with color-segmented fluorescence (CSF).
    Gynecol Oncol. 2017;146:676-677.
    PubMed     Abstract available

    August 2017
  275. HEIJKOOP ST, Nout RA, Quint S, Mens JWM, et al
    Dynamics of patient reported quality of life and symptoms in the acute phase of online adaptive external beam radiation therapy for locally advanced cervical cancer.
    Gynecol Oncol. 2017 Aug 19. pii: S0090-8258(17)31247.
    PubMed     Abstract available

    July 2017
  276. CHAN JK, Deng W, Higgins RV, Tewari KS, et al
    A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Jul 17. pii: S0090-8258(17)30889.
    PubMed     Abstract available

  277. DE AZEVEDO CRAS, Thuler LCS, de Mello MJG, de Oliveira Lima JT, et al
    Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31023.
    PubMed     Abstract available

  278. QIAN Y, Pollom EL, Nwachukwu C, Seiger K, et al
    Extent of lymphovascular space invasion may predict lymph node metastasis in uterine serous carcinoma.
    Gynecol Oncol. 2017 Jul 11. pii: S0090-8258(17)31137.
    PubMed     Abstract available

  279. LENNOX GK, Covens A
    Management Of Early Stage Cervical Cancer: When Is Non-Randomized Data Good Enough?
    Gynecol Oncol. 2017;146:1-2.

    June 2017
  280. MOSS HA, Havrilesky LJ, Chino J
    Insurance coverage among women diagnosed with a gynecologic malignancy before and after implementation of the Affordable Care Act.
    Gynecol Oncol. 2017 Jun 19. pii: S0090-8258(17)30953.
    PubMed     Abstract available

  281. CASTLE PE, Kinney WK, Cheung LC, Gage JC, et al
    Why does cervical cancer occur in a state-of-the-art screening program?
    Gynecol Oncol. 2017 Jun 10. pii: S0090-8258(17)30898.
    PubMed     Abstract available

  282. CHUNG TKH, Cheung TH, Yim SF, Yu MY, et al
    Liquid biopsy of PIK3CA mutations in cervical cancer in Hong Kong Chinese women.
    Gynecol Oncol. 2017 Jun 3. pii: S0090-8258(17)30894.
    PubMed     Abstract available

  283. MATSUMOTO Y, Mabuchi S, Kozasa K, Kuroda H, et al
    The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.
    Gynecol Oncol. 2017;145:469-475.
    PubMed     Abstract available

    May 2017
  284. KANAO H, Aoki Y, Hisa T, Takeshima N, et al
    Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
    Gynecol Oncol. 2017 May 30. pii: S0090-8258(17)30886.
    PubMed     Abstract available

  285. STEEN R, Dahl AA, Hess SL, Kiserud CE, et al
    A study of chronic fatigue in Norwegian cervical cancer survivors.
    Gynecol Oncol. 2017 May 25. pii: S0090-8258(17)30884.
    PubMed     Abstract available

  286. WOLF B, Ganzer R, Stolzenburg JU, Hentschel B, et al
    Extended mesometrial resection (EMMR): Surgical approach to the treatment of locally advanced cervical cancer based on the theory of ontogenetic cancer fields.
    Gynecol Oncol. 2017 May 16. pii: S0090-8258(17)30845.
    PubMed     Abstract available

  287. KAMRAN SC, Manuel MM, Cho LP, Damato AL, et al
    Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.
    Gynecol Oncol. 2017;145:284-290.
    PubMed     Abstract available

  288. DATTA NR, Stutz E, Liu M, Rogers S, et al
    Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2017;145:374-385.
    PubMed     Abstract available

    April 2017
  289. LEE J, Lin JB, Chang CL, Jan YT, et al
    Prophylactic lower para-aortic irradiation using intensity-modulated radiotherapy mitigates the risk of para-aortic recurrence in locally advanced cervical cancer: A 10-year institutional experience.
    Gynecol Oncol. 2017 Apr 27. pii: S0090-8258(17)30797.
    PubMed     Abstract available

  290. HARPER DM, DeMars LR
    HPV vaccines - A review of the first decade.
    Gynecol Oncol. 2017 Apr 22. pii: S0090-8258(17)30774.
    PubMed     Abstract available

  291. BAIOCCHI G, de Brot L, Faloppa CC, Mantoan H, et al
    Is parametrectomy always necessary in early-stage cervical cancer?
    Gynecol Oncol. 2017 Apr 6. pii: S0090-8258(17)30769.
    PubMed     Abstract available

  292. LI H, Sheng Y, Zhang Y, Gao N, et al
    MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Gynecol Oncol. 2017 Apr 3. pii: S0090-8258(17)30062.
    PubMed     Abstract available

    March 2017
  293. RADER JS, Sill MW, Beumer JH, Lankes HA, et al
    A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.
    Gynecol Oncol. 2017 Mar 9. pii: S0090-8258(17)30161.
    PubMed     Abstract available

  294. WANG YM, Wang CJ, Fang FM, Chen HC, et al
    Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study.
    Gynecol Oncol. 2017 Mar 5. pii: S0090-8258(17)30155.
    PubMed     Abstract available

    February 2017
  295. RING KL, Yemelyanova AV, Soliman PT, Frumovitz MM, et al
    Potential immunotherapy targets in recurrent cervical cancer.
    Gynecol Oncol. 2017 Feb 20. pii: S0090-8258(17)30148.
    PubMed     Abstract available

  296. LAIRSON DR, Fu S, Chan W, Xu L, et al
    Mean direct medical care costs associated with cervical cancer for commercially insured patients in Texas.
    Gynecol Oncol. 2017 Feb 10. pii: S0090-8258(17)30122.
    PubMed     Abstract available

  297. SALVO G, Ramirez PT, Levenback CF, Munsell MF, et al
    Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer.
    Gynecol Oncol. 2017 Feb 7. pii: S0090-8258(17)30116.
    PubMed     Abstract available

  298. VERLOOP J, van Leeuwen FE, Helmerhorst TJ, de Kok IM, et al
    Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.
    Gynecol Oncol. 2017;144:305-311.
    PubMed     Abstract available

    January 2017
  299. HO CK, Kornaga EN, Klimowicz AC, Enwere EK, et al
    Expression of DNA damage response proteins in cervical cancer patients treated with radical chemoradiotherapy.
    Gynecol Oncol. 2017 Jan 25. pii: S0090-8258(16)31689.
    PubMed     Abstract available

  300. LEE YJ, Kim DY, Lee SW, Park JY, et al
    A postoperative scoring system for distant recurrence in node-positive cervical cancer patients after radical hysterectomy and pelvic lymph node dissection with para-aortic lymph node sampling or dissection.
    Gynecol Oncol. 2017 Jan 17. pii: S0090-8258(17)30001.
    PubMed     Abstract available

  301. ALEXANDRE E, Sebastien G, Renaud M, Enrica B, et al
    Outcome of early stage cervical cancer patients treated according to a radiosurgical approach: Clinical results and prognostic factors.
    Gynecol Oncol. 2017 Jan 14. pii: S0090-8258(16)31690.
    PubMed     Abstract available

  302. SWAILES AL, Gockley A, Phaeton R, Kesterson JP, et al
    The Wertheim hysterectomy: Development, modifications, and impact in the present day.
    Gynecol Oncol. 2017 Jan 13. pii: S0090-8258(17)30049.
    PubMed     Abstract available

  303. BEDELL S, Manders D, Kehoe S, Lea J, et al
    The opinions and practices of providers toward the sexual issues of cervical cancer patients undergoing treatment.
    Gynecol Oncol. 2017 Jan 9. pii: S0090-8258(16)31686.
    PubMed     Abstract available

  304. ANGIOLO G, Silvestro C, Giovanni A
    Neuroendrocrine tumors of the uterine cervix: A therapeutic challenge for gynecologic oncologists.
    Gynecol Oncol. 2017 Jan 2. pii: S0090-8258(16)31621.
    PubMed     Abstract available

    Sentinel Lymph Node Biopsy for Cervical Cancer Patients - What's It Gonna Take?
    Gynecol Oncol. 2017;144:3-4.

  306. WRIGHT TC JR, Behrens CM, Ranger-Moore J, Rehm S, et al
    Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Gynecol Oncol. 2017;144:51-56.
    PubMed     Abstract available

  307. FRUMOVITZ M, Munsell MF, Burzawa JK, Byers LA, et al
    Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix.
    Gynecol Oncol. 2017;144:46-50.
    PubMed     Abstract available

    November 2016
  308. SAPIENZA LG, Gomes MJ, Calsavara VF, Leitao MM Jr, et al
    Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials.
    Gynecol Oncol. 2016 Nov 28. pii: S0090-8258(16)31613.
    PubMed     Abstract available

  309. KUJI S, Watanabe R, Sato Y, Iwata T, et al
    A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases.
    Gynecol Oncol. 2016 Nov 28. pii: S0090-8258(16)31576.
    PubMed     Abstract available

  310. ROSS GREEN W, Hathout L, Khan AJ, Elshaikh MA, et al
    Revisiting Milan cervical cancer study: Do the original findings hold in the era of chemotherapy?
    Gynecol Oncol. 2016 Nov 26. pii: S0090-8258(16)31603.
    PubMed     Abstract available

  311. BEACHLER DC, Tota JE, Silver MI, Kreimer AR, et al
    Trends in cervical cancer incidence in younger US women from 2000 to 2013.
    Gynecol Oncol. 2016 Nov 25. pii: S0090-8258(16)31600.
    PubMed     Abstract available

  312. SULLIVAN SA, Clark LH, Staley AS, Tran AQ, et al
    Association between timing of cervical excision procedure to minimally invasive hysterectomy and surgical complications.
    Gynecol Oncol. 2016 Nov 25. pii: S0090-8258(16)31606.
    PubMed     Abstract available

  313. KONG TW, Lee JD, Son JH, Paek J, et al
    Corrigendum to 'Treatment outcomes in patients with FIGO stage IB-IIA cervical cancer and a focally disrupted cervical stromal ring on magnetic resonance imaging: A propensity score matching study' [Gynecol. Oncol. 143 (2016) 77-82].
    Gynecol Oncol. 2016 Nov 24. pii: S0090-8258(16)31522.

  314. SMITH B, McCann GA, Phillips G, Backes FJ, et al
    Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?
    Gynecol Oncol. 2016 Nov 21. pii: S0090-8258(16)31598.
    PubMed     Abstract available

  315. SHIM SH, Kim DY, Lee SJ, Kim SN, et al
    Prediction model for para-aortic lymph node metastasis in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2016 Nov 14. pii: S0090-8258(16)31568.
    PubMed     Abstract available

  316. DEL CARMEN MG, Rice LW
    International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
    Gynecol Oncol. 2016 Nov 12. pii: S0090-8258(16)31572.

    October 2016
  317. KIM JY, Byun SJ, Kim YS, Nam JH, et al
    Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer.
    Gynecol Oncol. 2016 Oct 24. pii: S0090-8258(16)31509.
    PubMed     Abstract available

  318. HAQUE W, Verma V, Fakhreddine M, Hatch S, et al
    Addition of chemotherapy to definitive radiotherapy for IB1 and IIA1 cervical cancer: Analysis of the National Cancer Data Base.
    Gynecol Oncol. 2016 Oct 23. pii: S0090-8258(16)31510.
    PubMed     Abstract available

  319. MAHMOUD O, Hathout L, Shaaban SG, Elshaikh MA, et al
    Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
    Gynecol Oncol. 2016 Oct 18. pii: S0090-8258(16)31499.
    PubMed     Abstract available

  320. FLEMING ND, Ramirez PT, Soliman PT, Schmeler KM, et al
    Quality of life after radical trachelectomy for early-stage cervical cancer: A 5-year prospective evaluation.
    Gynecol Oncol. 2016 Oct 11. pii: S0090-8258(16)31484.
    PubMed     Abstract available

  321. LENNOX GK, Covens A
    Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?
    Gynecol Oncol. 2016 Oct 11. pii: S0090-8258(16)31358.
    PubMed     Abstract available

  322. BARRINGTON DA, Dilley SE, Landers EE, Thomas ED, et al
    Distance from a Comprehensive Cancer Center: A proxy for poor cervical cancer outcomes?
    Gynecol Oncol. 2016 Oct 6. pii: S0090-8258(16)31475.
    PubMed     Abstract available

  323. CHO LP, Manuel M, Catalano P, Lee L, et al
    Outcomes with volume-based dose specification in CT-planned high-dose-rate brachytherapy for stage I-II cervical carcinoma: A 10-year institutional experience.
    Gynecol Oncol. 2016 Oct 6. pii: S0090-8258(16)31423.
    PubMed     Abstract available

    September 2016
  324. MISHKIN G, Minasian LM, Kohn EC, Noone AM, et al
    The generalizability of NCI-sponsored clinical trials accrual among women with gynecologic malignancies.
    Gynecol Oncol. 2016 Sep 30. pii: S0090-8258(16)31432.
    PubMed     Abstract available

  325. WHITE ID, Sangha A, Lucas G, Wiseman T, et al
    Assessment of sexual difficulties associated with multi-modal treatment for cervical or endometrial cancer: A systematic review of measurement instruments.
    Gynecol Oncol. 2016 Sep 23. pii: S0090-8258(16)31359.
    PubMed     Abstract available

  326. WILBUR MB, Mannschreck DB, Angarita AM, Matsuno RK, et al
    Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.
    Gynecol Oncol. 2016 Sep 21. pii: S0090-8258(16)31426.
    PubMed     Abstract available

  327. STECKLEIN SR, Jhingran A, Burzawa J, Ramalingam P, et al
    Patterns of recurrence and survival in neuroendocrine cervical cancer.
    Gynecol Oncol. 2016 Sep 16. pii: S0090-8258(16)31409.
    PubMed     Abstract available

  328. ROBIN TP, Amini A, Schefter TE, Behbakht K, et al
    Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer.
    Gynecol Oncol. 2016 Sep 15. pii: S0090-8258(16)31412.
    PubMed     Abstract available

    August 2016
  329. RENDON GJ, Echeverri L, Echeverri F, Sanz-Lomana CM, et al
    Outpatient laparoscopic nerve-sparing radical hysterectomy: A feasibility study and analysis of perioperative outcomes.
    Gynecol Oncol. 2016 Aug 9. pii: S0090-8258(16)31256.
    PubMed     Abstract available

    May 2016
  330. LIAO JB
    Immunotherapy for Gynecologic Cancers: State of the Science.
    Gynecol Oncol. 2016 May 27. pii: S0090-8258(16)30758.

    March 2016
  331. MANLEY KM, Wills AK, Morris GC, Hogg JL, et al
    The impact of HPV cervical screening on negative large loop excision of the transformation zone (LLETZ): A comparative cohort study.
    Gynecol Oncol. 2016 Mar 28. pii: S0090-8258(16)30088.
    PubMed     Abstract available

    February 2016
  332. DE STROOPER LM, Verhoef VM, Berkhof J, Hesselink AT, et al
    Validation of the FAM19A4/mir124-2 DNA methylation test for both lavage- and brush-based self-samples to detect cervical (pre)cancer in HPV-positive women.
    Gynecol Oncol. 2016 Feb 24. pii: S0090-8258(16)30036.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.